Myxedema coma.
D000311:Adrenal Glands / Q000503:physiopathology; D002100:Cachexia / Q000150:complications; D002490:Central Nervous System / Q000503:physiopathology; D003128:Coma / Q000188:drug therapy / Q000209:etiology*; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007003:Hypoglycemia / Q000150:complications; D007010:Hyponatremia / Q000150:complications; D007022:Hypotension / Q000150:complications; D007031:Hypothalamus / Q000503:physiopathology; D007035:Hypothermia / Q000150:complications; D007239:Infections / Q000150:complications; D007415:Intestinal Obstruction / Q000150:complications; D008168:Lung / Q000503:physiopathology; D009119:Muscle Contraction; D009132:Muscles / Q000503:physiopathology; D009230:Myxedema / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010902:Pituitary Gland / Q000503:physiopathology; D012131:Respiratory Insufficiency / Q000150:complications; D013963:Thyroid Hormones / Q000627:therapeutic use; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D014555:Urination Disorders / Q000150:complications
D013963:Thyroid Hormones; D014284:Triiodothyronine; D013974:Thyroxine